|
|
| Titre |
Abstract :
A Randomized Trial of Exemestane after Two to Three Years
of Tamoxifen Therapy in Postmenopausal Women
with Primary Breast Cancer
|
 |
|
| Auteur |
in file |
|
| Site |
../pdf/publications/IESPacs02ArticleComplet.pdf |
|
|
| Date de publication |
n engl j med 350;11 March 11, 2004 |
|
| Titre |
Poster :
on behalf of the IGGEFFICACE consortiumIntegration of geriatrics, genomics and ethics for fighting increasing cases of cancer in the elderly.Congrès SIOG 21- |
|
|
| Auteur |
F Pein, L Repetto, AC Braud, I Irminger, B Tranchand, J Meran, M Aapro |
|
| Date de publication |
22/11/2003 à Rome |
|
| Titre |
Poster :
Phase-II impact study on Activities Daily Living (ADL) of a capecitabine and vinorelbine oral combination in the treatment of advanced or metastatic breast, lung or prostate carcinoma in patients aged of 70 and older.
A preliminary report of the first « GERICO » study by the French FNCLCC collaborative group.
|
|
|
| Auteur |
Braud AC, Joly F, Rios M, Felizot L, Fargeot P, Servent V, Laguerre B, Turpin F and Pein F |
|
| Date de publication |
Congrès SIOG 21-22/11/2003 à Rome. |
|
| Titre |
Poster :
High-dose chemotherapy with autogelous stem cell transplantation in poor prognosis germ cell tumors .
The TAXIF Protocol or Two Semi-Intensive Chemotherapy Cycles Followed by Three High-Dose Cycles.
|
|
|
| Auteur |
J. P. Lotz , B. Bui , C. Théodore , K. Fizazi , A. Caty , G. Gravis , R. Delva , A. Thyss , J. Peny , P. Viens , B. Duclos , T. De Revel , H. Curé , J. Gligorov , S. Culine , S. Provent , J. P. Droz , P. Biron , F. Gomez , C. Ségura , S. Guillemaut |
|
| Date de publication |
Congrès ECCO – Autriche sept 2003. |
|
| Titre |
Poster :
ISCB poster : IES Study a model for collaboration
3rd International Society for Clinical Biostatistic & Society for Clinical Trial |
|
|
| Auteur |
Gibson L., Hall E., Bliss JM, Emson MA, Carpentieri M, Massimini G, Coombes RC. |
|
| Date de publication |
Conference – London July 20-24, 2003. |
|
| Titre |
Safety analysis of the PACS 01 adjuvant trial comparing 6 cycles of FEC 100 to 3 cycles of FEC 100 followed by 3 cycles of docetaxel Taxotere® for node positive breast cancer.
Breast Cancer Research and Treatment, 26th Annual San Antonio Breast Cace |
|
|
| Auteur |
Roche H, SpielmannM, Fumoleau P, Canon JL, et all |
|
| Date de publication |
Symposium 2003, Vol 82:Supplement 1;S32. |
|
| Titre |
LV5FU2+CPT-11 versus LV5FU2 alone in adjuvant colon cancer: interim safety results of the national randomized FNCLCC ACCORD02/FFCD9802 phase III trial. |
|
|
| Auteur |
Ychou Marc, MD, Raoul JL, Douillard JY, Bugat R, Mineur L, Giovannini M, Bécouarn Y, Jacob JH, Bouché O, Gourgou S. |
|
| Titre |
Titre :
Dosimetric data of the French randomized trial comparing 70Gy vs 80Gy 3D-CRT in the prostate cancer. |
|
|
| Auteur |
V.Beckendorf, B. Lavigne, L. Vieillevigne, P.Aletti, G. Gaboriaud, H. Aget, R. Oozeer,M. Simonian-Sauve, I. Sentenac, A. Lisbona, P. François, F. Bidault, S. Marcié, S. Estivalet, D. Le Du, C. Ginestet, R. Delard, P. Bey. |
|
| Date de publication |
Abstract N° ESTRO radiophysique à Genève 20 |
|
| Titre |
Quality-of-life (QOL) assessment after concurrent chemoradiation for invasive bladder cancer. Preliminary results of a French multicenter prospective study.
International Journal of Radiation Oncology*Biology*Physics
Volume 57, Issue 2, Supplement 1
|
|
|
| Auteur |
Chauvet B, Lagrange JL, Geoffrois L, Beckendorf V, Ferrero JM, Joly F, Allouache N, Bachaud JM, Chevreau C, Mollevi C, Kramar A. |
|
| Site |
http://www.sciencedirect.com/science/journal/03603016 |
|
|
| Date de publication |
1 October 2003, Pages S152-S153 |
|
| Titre |
The French 70 Gy versus 80 Gy dose escalation trial for localized prostate cancer : feasibility and toxicity
International Journal of Radiation Oncology*Biology*Physics
Volume 57, Issue 2, Supplement 1 |
|
|
| Auteur |
V.Beckendorf, S. Guerif, E. Le Prisé, P. Bey, J.M. Cosset, O. Lefloch, B. Chauvet, N. salem, O. Chapet, S. Bourdin, J.M. Bachaud, P. Maingon, J.L. Lagrange, L. Malissard, J.M. Simon, P. Pommier, M.H. Hay |
|
| Site |
http://www.sciencedirect.com/science/journal/03603016 |
|
|
| Date de publication |
1 October 2003, Page S177 |
|
| Titre |
Nouvelle Directive européenne : un obstacle supplémentaire pour la recherché institutionnelle ? |
|
|
| Auteur |
J. Genève |
|
| Date de publication |
Oncologie 2003 ;5 :S55-S56 |
|
| Titre |
Imperial College of Science, Technology & Medicine, London, UK; Institute of Cancer Research, London, UK; University of Sussex, Brighton, UK; Pharmacia Italia SpA, Milan, Italy
Under-reporting of symptoms in patients with early breast cancer (EBC) who have received tamoxifen treatment for 2-3 years.
|
|
|
| Auteur |
C. Coombes, J. Bliss, E. Hall, L. Gibson, L. Fallowfield, G. Massimini, for the Intergroup Exemestane Study |
|
| Date de publication |
Proc Am Soc Clin Oncol 22: page 13, 2003 (abstr 48 |
|
| Titre |
Group on High Dose Chemotherapy and Stem Cell Transplantation in Breast Cancer (PEGASE).
Can sequential administration minimize cost of high dose chemotherapy ? An economic assessment in inflammatory breast cancer.
|
|
|
| Auteur |
Marino P., Le Coroller A.G., Palagié T., Janvier M. et all |
|
| Date de publication |
Pharmacoeconomics 2003; 21 (11): 807-818. |
|
| Titre |
High-dose chemotherapy for breast cancer: the French PEGASE experience. |
|
|
| Auteur |
Roche H, Viens P, Biron P, Lotz JP, Asselain B; PEGASE Group. |
|
| Date de publication |
Cancer Control. 2003 Jan-Feb;10(1):42-7. |
|
| Titre |
Gemcitabine and cisplatin (GC) as adjuvant chemotherapy for locally advanced bladder cancer (LABC) after cystectomy: preliminary results of a feasibility study. |
|
|
| Auteur |
Jean-Pierre Droz, Karim Fizazi, Philippe Beuzeboc, Catherine Guillemare, Christine Theodore, Lionel Geoffrois, Nicolas Mottet, Christine Chevreau, Sophie Gourgou, Stéphane Culine, Genito-Urinary Group of the French Federation of Cancer Centers (GETUG). |
|
| Date de publication |
Abstract No: 2425 – ASCO 2002 |
|
| Titre |
Titre :
High dose (HD) topotecan (TPC) with blood stem cells support (BSCS) in ovarian carcinoma (OC): a phase I study (ITOV 01 protocol).
Auteurs :
Catherine Lhomme, Jean-Pierre Lotz, Michel Fabbro, Patricia Pautier, Francois Lokiec, Vincent Ribrag, Frédéric Selle, Brigitte Gosse, Stéphane Provent, Guillaume Lefevre, Alfredo Saavedra, Mireille Le Bonniec, Christian Cailliot, Dominique Maraninchi, Jean Genève, Patrice Viens. |
|
|
| Date de publication |
Abstract No: 861- ASCO 2002 |
|
| Titre |
High dose thiotepa (TTP), cyclophosphamide (CPM) and stem cell transplantation after 4 FEC 100 compared with 4 FEC alone allowed a better disease free survival but the same overall survival in first line chemotherapy for metastatic breast cancer. Results of the PEGASE 03 French Protocole. |
|
|
| Auteur |
Pierre Biron, Michel Durand, Henri Roche, Thierry Delozier, Camillo Battista, Pierre Fargeot, D Spaeth, T Bachelot, E Poiget, F Monnot, ML Tanguy, H Cure. |
|
| Date de publication |
Abstract No: 167 – ASCO 2002 |
|
| Titre |
Refractory germ-cell tumors (GCTS): salvage high-dose chemotherapy (HD-CT) combining 2 mobilization regimens followed by 3 HD-CT with peripheral blood stem cell transplantation (PBSCT): the ''Taxif'' protocol (GETUG Group). |
|
|
| Auteur |
Jean-Pierre Lotz, Bin Bui, Christine Théodore, Armelle Caty, Karim Fizazi, Gwenaelle Gravis, Remy Delva, Brigitte Duclos, Jean Peny, Stéphane Culine, Thierry De Revel, Frédéric Gomez, Joseph Gligorov, Stéphane Provent, Jean-Pierre Droz, Pierre Biron . |
|
| Date de publication |
Abstract No: 744 – ASCO 2002 |
|
| Titre |
Doxorubicin and ifosfamide in patients with metastatic sarcomatoid renal cell carcinoma: a phase II study of the Genitourinary Group of the French Federation of Cancer Centers. |
|
|
| Auteur |
Escudier B, Droz JP, Rolland F, Terrier-Lacombe MJ, Gravis G, Beuzeboc P, Chauvet B, Chevreau C, Eymard JC, Lesimple T, Merrouche Y, Oudard S, Priou F, Guillemare C, Gourgou S, Culine S; Genitourinary Group of the French Federation of Cancer Centers. |
|
| Site |
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=12187199&dopt=Abstract |
|
|
| Date de publication |
J Urol. 2002 Sep;168(3):959-61. |
|
| Titre |
Etoposide plus cisplatin with or without the combination of 4'-epidoxorubicin plus cyclophosphamide in treatment of extensive small-cell lung cancer: a French Federation of Cancer Institutes multicenter phase III randomized study. |
|
|
| Auteur |
Pujol JL, Daures JP, Riviere A, Quoix E, Westeel V, Quantin X, Breton JL, Lemarie E, Poudenx M, Milleron B, Moro D, Debieuvre D, Le Chevalier T. |
|
| Site |
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=11181777&dopt=Abstract |
|
|
| Date de publication |
J Natl Cancer Inst 2001 Feb 21;93(4):300-8 |
|
| Titre |
Tamoxifen adjuvant treatment duration in early breast cancer: initial results of a randomized study comparing short-term treatment with long-term treatment. Federation Nationale des Centres de Lutte Contre le Cancer Breast Group. |
|
|
| Auteur |
Delozier T, Spielmann M, Mace-Lesec'h J, Janvier M, Hill C, Asselain B, Julien JP, Weber B, Mauriac L, Petit JC, Kerbrat P, Malhaire JP, Vennin P, Leduc B, Namer M. |
|
| Site |
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=11032592&dopt=Abstract |
|
|
| Date de publication |
J Clin Oncol 2000 Oct 15;18(20):3507-12 |
|
| Titre |
High-dose platinum versus standard dose in advanced ovarian carcinoma: a randomized trial from the Gynecologic Cooperative Group of the French Comprehensive Cancer Centers (FNCLCC). |
|
|
| Auteur |
Joly F, Heron JF, Kerbrat P, Chauvergne J, Rios M, Mayer F, Chinet-Charrot P, Goupil A, Lebrun-Jezekova D, Vennin D, Lhomme C, Mace-Lesec'h J, Crouet H. |
|
| Site |
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=10985895&dopt=Abstract |
|
|
| Date de publication |
Gynecol Oncol 2000 Sep;78(3 Pt 1):361-8 |
|
| Titre |
High-Dose Sequential Chemotherapy With Recombinant Granulocyte Colony-Stimulating Factor and Repeated Stem-Cell Support for Inflammatory Breast Cancer Patients: Does Impact on Quality of Life Jeopardize Feasibility and Acceptability of Treatment? |
|
|
| Auteur |
Macquart-Moulin G, Viens P, Palangie T, Bouscary ML, Delozier T, Roche H, Janvier M, Fabbro M, Moatti JP. |
|
| Site |
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=10673516&dopt=Abstract |
|
|
| Date de publication |
J Clin Oncol. 2000 Feb 14;18(4):754. |
|
| Titre |
First-line high-dose sequential chemotherapy with rG-CSF and repeated blood stem cell transplantation in untreated inflammatory breast cancer: toxicity and response (PEGASE 02 trial).
|
|
|
| Auteur |
Viens P, Palangie T, Janvier M, Fabbro M, Roche H, Delozier T, Labat JP, Linassier C, Audhuy B, Feuilhade F, Costa B, Delva R, Cure H, Rousseau F, Guillot A, Mousseau M, Ferrero JM, Bardou VJ, Jacquemier J, Pouillart P. |
|
| Site |
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=10507769&dopt=Abstract |
|
|
| Date de publication |
Br J Cancer. 1999 Oct;81(3):449-56. |
|
| Titre |
Phase II trial of oxaliplatin as first-line chemotherapy in metastatic colorectal cancer patients. Digestive Group of French Federation of Cancer Centers. |
|
|
| Auteur |
Becouarn Y, Ychou M, Ducreux M, Borel C, Bertheault-Cvitkovic F, Seitz JF, Nasca S, Nguyen TD, Paillot B, Raoul JL, Duffour J, Fandi A, Dupont-Andre G, Rougier P. |
|
| Site |
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=9704726&dopt=Abstract |
|
|
| Date de publication |
J Clin Oncol. 1998 Aug;16(8):2739-44. |
|
| Titre |
[Chemoprevention of cancer of the breast. Position statement on July 3, 1998 of the Fedration Nationale des Centres de Lutte Contre le Cancer (FNCLCC)]. |
|
|
| Auteur |
Eisinger F, Espie M, Kuttenn F, Lasset C, de Lignieres B, Namer M, Roche H, Sasco A, Serin D, Philip T. |
|
| Site |
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=9754082&dopt=Abstract |
|
|
| Date de publication |
Bull Cancer. 1998 Aug;85(8):725. French. No abstra |
|
| Titre |
Concomitant b.i.d. radiotherapy and chemotherapy with cisplatin and 5-fluorouracil in unresectable squamous-cell carcinoma of the pharynx: clinical and pharmacological data of a French multicenter phase II study. |
|
|
| Auteur |
Bensadoun RJ, Etienne MC, Dassonville O, Chauvel P, Pivot X, Marcy PY, Prevost B, Coche-Dequeant B, Bourdin S, Vallicioni J, Poissonnet G, Courdi A, Teissier E, Lagrange JL, Thyss A, Santini J, Demard F, Schneider M, Milano G. |
|
| Site |
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=9788400&dopt=Abstract |
|
|
| Date de publication |
Int J Radiat Oncol Biol Phys. 1998 Sep 1;42(2):237 |
|
| Titre |
Phase II trial of intraperitoneal carboplatin in ovarian carcinoma patients with macroscopic residual disease at second-look laparotomy. A multicentre study of the French Federation Nationale des Centres de Lutte Contre le Cancer. |
|
|
| Auteur |
Guastalla JP, Lhomme C, Kerbrat P, Mayer F, Namer M, Goupil P, Charrot P, Heron JF, Chazard M, Richard I, et al. |
|
| Site |
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=8186155&dopt=Abstract |
|
|
| Date de publication |
Ann Oncol 1994 Feb;5(2):127-32 |
|
|
|
